The Food and Drug Association (FDA) is calling for patient perspectives to inform their understanding of the severity of breast cancer and available breast cancer therapies.
If you are you living with breast cancer or providing care for someone who is, if you’re a patient advocate; if you want to influence how that FDA understands breast cancer therapies, register now for the upcoming FDA’s Public Meeting on Breast Cancer on April 2nd and bring your important patient voice to the FDA.
Patients and consumers depend on the FDA to ensure that medical drugs and devices are safe and effective. That’s why we work to ensure that the FDA approval process puts patients before profits and that any new breast cancer therapies and devices are more effective, less toxic or less expensive than previous ones.
This meeting is a unique opportunity to share your perspective on symptoms of breast cancer that matter most, including the impact of breast cancer on daily life and current approaches to treating breast cancer.
When: April 2, 2015, from 1 p.m. to 5 p.m.
Where: Food and Drug Administration White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993. (Participants must enter through Building 1 and undergo security screening).
Meeting format: A brief initial patient panel discussion will be followed by a facilitated discussion inviting comments from other patients and patient stakeholder participants.
In order to focus on patient voices, members from academia, industry, and other groups will be present at this meeting attending in “listening mode” only.